Labdhi R Shah, Shwetambari Singh, Harshit Shah


PURPOSE: To study the post operative outcome of type I Boston keratoprosthesis (KPro).
MATERIALS AND METHODS: Evaluation of two eyes of two patients who underwent Boston type I KPro implantation between September
2016 and September 2017 with a mean follow up of 12 month period.
RESULTS: In the median follow-up of 12 months visual outcomes were not satisfactory. The main indication for surgery was multiple failed grafts
in both patients. Both patients demonstrated no significant improvement in vision; with pre-operative visual acuity of hand movements (HM),
counting fingers. No complications like Glaucoma or Retroprosthetic membranes were found. On fundus evaluation both patients had Optic
Atrophy which failed to improve vision.
CONCLUSION: There was no significant improvement of vision due to Optic Atrophy in both the patients. However, patients require close
lifelong follow-up to manage any complications.


operative outcome keratoprosthesis Boston evaluation

Full Text:



Khan B, Dudenhoefer EJ, Dohlman CH. Keratoprosthesis: an update. CurrOpinOphthalmol 2001;12:282-7.

Dunlap K, Chak G, Aquavella JV, Myrowitz E, Utine CA, Akpek E. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation. Ophthalmology 2010;117:687-92.

Ilhan-Sarac O, Akpek EK. Current concepts and techniques in keratoprosthesis. CurrOpinOphthalmol 2005;16:246-50.

Dohlman CH, Harissi-Dagher M. The Boston Keratoprosthesis: A New Threadless Design. Digi J Opthalmol 2007;13:6.

Dohlman CH, Dudenhoefer EJ, Khan BF, Morneault S. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. Clao J 2002;28:72-4.

Dudenhoefer EJ, Nouri M, Gipson IK, Baratz KH, Tisdale AS, Dryja TP, et al. Histopathology of explanted collar button keratoprostheses: A clinicopathologic correlation. Cornea 2003;22:424-8.

Sayegh RR, Avena DL, Vargas-Martin F, Webb RH, Dohlman CH, Peli E. Optical functional properties of the Boston Keratoprosthesis. Invest Ophthalmol Vis Sci 2010;51:857-63.

Al Arfaj K, Hantera M. Short-term visual outcomes of Boston keratoprosthesis type i in Saudi Arabia. Middle East Afr J Ophthalmol 2012;19:88-92.

Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol 2001;119:484-9.

Khan BF, Harissi-Dagher M, Khan DM, Dohlman CH. Advances in Boston keratoprosthesis: Enhancing retention and prevention of infection and inflammation. IntOphthalmolClin 2007;47:61-71.

Yaghouti F, Dohlman CH. Innovations in keratoprosthesis: Proved and unproved. IntOphthalmolClin 1999;39:27-36.

Zerbe BL, Belin MW, Ciolino JB. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 2006;113:1779.

Chew HF, Ayres BD, Hammersmith KM, Rapuano CJ, Laibson PR, Myers JS, et al. Boston keratoprosthesis outcomes and complications. Cornea 2009;28:989-96.


  • There are currently no refbacks.